Interferons Market: Current Analysis and Forecast (2022-2028)


Emphasis on Product (Interferon Gamma, Interferon Beta, and Interferon Alpha); Indication (Multiple Sclerosis, Polycythemia Vera, Hepatitis C, Melanoma, Chronic Granulomatous Disease (CGD), and Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)); Region (North America, Europe, Asia-Pacific, Rest of the World); and Region/Country







Report ID:



  Get a Sample
Report Description
Table of content
Research Methodology

Report Description

Interferons Market
Interferons Market

The global interferons market is expected to grow at a significant rate of around 4% during the forecast period. Interferons are an important protein of the immune system that is produced by white blood cells. Furthermore, the interferons are the natural defense against viral infection, bacterial infections, cancer, and other diseases. However, interferon can also be artificially synthesized which is used in the treatment of a number of diseases. Furthermore, the number of diseases that are responsible for rising cases of immunocompromisation in the population rises the demand for interferons. For instance, as per, there were approximately 38.4 million people across the globe with HIV in 2020. Of these, 36.7 million were adults and 1.7 million were children (<15 years old). In addition, 54% were women and girls

Roche, Merck & Co., Bristol-Myers Squibb, Biogen Inc., Bayer AG, Zydus Cadila, Novartis AG, Pfizer Inc., Biosidus, and Synairgen are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report

“Amongst product, interferon beta category to witness higher CAGR during the forecast period”

Based on the product, the market has been categorized into interferon gamma, interferon beta, and interferon alpha. The interferon-beta category is to witness a higher CAGR during the forecast period owing to its efficacy in the treatment of various brain disorders such as hepatitis. Additionally, the interferon beta also helps to reduce the episodes of relapsing-remitting which is a symptom of multiple sclerosis.

“Amongst indication, multiple sclerosis to hold a significant share in the market in 2020”

Based on the indication, the market has been categorized into multiple sclerosis, polycythemia vera, hepatitis c, melanoma, chronic granulomatous disease (CGD), and others. Among these, multiple sclerosis to hold a significant share of the market in 2020. Interferon treatment showed an impressive result in the treatment of multiple sclerosis is the one of main reasons for the rising demand for interferon in multiple sclerosis treatment. The higher number of multiple sclerosis incidences is an important factor for the growth of the interferon market.  For instance, as per the National MS Society, in 2019, nearly one million people are living with multiple sclerosis in the United States.

“Amongst distribution channels, the hospital pharmacies to hold a significant share in the market in 2020”

Based on the distribution channel, the market has been categorized into hospital pharmacies, retail pharmacies, online pharmacies, and others. Among these, hospital pharmacies to hold a significant share of the market in 2020. Hospital pharmacies represent one of the most lucrative options for patients for the consumables of drugs. Apart from this, several physicians require the presence of a trained physician and are therefore expected to drive segmental growth.

“North America to hold a significant share in the market”

For a better understanding of the market adoption of the interferons industry, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. In 2020, North America held a significant share of the global Interferons market. This is mainly attributed to the rising number of product launches and the increasing healthcare investments in the region. For instance, in November 2021, PharmaEssentia Corporation announced that the U.S. Food and Drug Administration (FDA) has approved BESREMi® (ropeginterferon alfa-2b-njft) for the treatment of adults with polycythemia vera (PV). Furthermore, the rising geriatric population in the region is also an important factor that increases the market size of interferons in North America.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
  • The report presents a quick review of overall industry performance at one glance.
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
  • The study comprehensively covers the market across different segments.
  • Deep dive regional level analysis of the industry.

Customization Options:

The global interferons market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

1.1.Market Definitions
1.2.Main Objective
2.1.Research Process of the Interferons Market
2.2.Research Methodology of the Interferons Market
2.3.Respondent Profile  
7.1.Interferon Gamma
7.2.Interferon Beta
7.3.Interferon Alpha
8.1.Multiple Sclerosis 
8.2.Polycythemia Vera 
8.3.Hepatitis C 
8.5.Chronic Granulomatous Disease (CGD)
9.1.Hospital Pharmacies
9.2.Retail Pharmacies
9.3.Online Pharmacies
10.1.North America  
 10.1.3.Rest of North America
 10.2.6.Rest of Europe
 10.3.4.Rest of Asia-Pacific
10.4.Rest of World 
11.1.Market Drivers
11.2.Market Challenges
11.3.Impact Analysis
14.1.Demand Side Analysis
14.2.Supply Side Analysis 
16.1.Competitive Landscape 
 16.1.1.Porters Fiver Forces Analysis
17.2.Merck & Co.
17.3.Bristol-Myers Squibb
17.4.Biogen Inc.
17.5.Bayer AG 
17.6.Zydus Cadila
17.7.Novartis AG
17.8.Pfizer Inc. 

Research Methodology

Research Methodology for the Interferons Market Analysis (2022-2028)

Analyzing the historical market, estimating the current market, and forecasting the future market of the global interferons market were the three major steps undertaken to create and analyze the adoption of interferons in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global interferons market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the Interferons market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the Interferons market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as product, indication, and distribution channel. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the interferons market. Further, we conducted factor analysis using dependent and independent variables such as various products, indication, and distribution channel of interferons. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the Interferons market sector across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global Interferons market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2027 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of revenue (USD) and the adoption rate of the interferons market across the major markets domestically
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in the global interferons market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Interferons Market
Interferons Market

Market Engineering

The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global Interferons market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of product, indication, and distribution channel in the global interferons market.

The main objective of the Global Interferons Market Study

The current & future market trends of the global Interferons market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of the interferons market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
  • Segments in the study include areas of product, indication, and distribution channel.
  • Define and analysis of the regulatory framework for the interferons
  • Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry.
  • Analyze the current and forecast market size of the interferons market for the major region.
  • Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World.
  • Company profiles of the interferons market and the growth strategies adopted by the market players to sustain in the fast-growing market
  • Deep dive regional level analysis of the industry

You can also purchase parts of this report. Do you want to check out a section wise
price list?